The VERITY Steering Committee
Post on 03-Jan-2016
28 Views
Preview:
DESCRIPTION
Transcript
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
The VERITY Steering Committee
Third Venous ThromboembolismRegistry Report
2005
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Schematic of the report production process
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
List of contributors
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
List of contributors
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
List of contributors
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Example table
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Number of risk factors for patients with VTE (n=4,603)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Overview
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Database overview
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
The growth of the database (n=27,179)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Data submitted by each centre
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Number of risk factors and diagnosis
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Number of risk factors for patients with VTE (n=4,603)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Final diagnosis and the number of risk factors (n=17,175)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Age distribution for all patients with VTE (n=27,123)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Final diagnosis over time (n=21,486)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Age and gender for patients with VTE
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Age and gender for patients with VTE (n=6,045)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Age and gender for patients with VTE and Cancer (n=799)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Rates of different risk factors in patients who have VTE
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Presence of various risk factors and final diagnosis
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Task Force of the British Committee for Standards in Haematology13
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
D-dimer result and final diagnosis
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Final diagnosis and D-dimer test (n=16,005)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
D-dimer result, DVT pre-test probability and final diagnosis
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Final diagnosis, D-dimer result, D-dimer test and DVT pre-test probability (n=11,585)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Suitability for home treatment1 amongst patients with confirmed DVT (n=5,371)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Reason patients with DVT were deemed unsuitable for home treatment; (patients unsuitable for home treatment with recorded reason n=466)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Duration of LMWH therapy and time to therapeutic INR in patients with DVT; patients receiving both treatments only (n=3,248)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Kaplan-Meier survival curves for patients with confirmed diagnosis of DVT and PE (n=2,224)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Pulmonary embolism
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Primary and final diagnosis
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Numbers of risk factors
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Number of risk factors according to final diagnosis (n=4,603)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Different risk factors
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Presence of selected risk factors for PE and non-PE patients
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Age and disease
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Age distributions according to final diagnosis (n=6,115)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
A. Management of suspected non-massive pulmonary embolism with isotope lung scanning off site only
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
B. Management of suspected non-massive pulmonary embolism with isotope lung scanning available on site
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
PTP score and final diagnosis
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
PTP score distributions for patients with confirmed PE and non-PE patients (n=279 and n=342 respectively)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
PTP score distributions for patients with confirmed PE and non-PE patients (n=279 and n=342 respectively)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
PTP score D-dimer and final diagnosis
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Final diagnosis, D-dimer results and PE PTP score for patients with a suspected PE (n=438)
Using <4 and ≥4 to classify the PE PTP score
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Final diagnosis, D-dimer results and PE PTP score for patients with a suspected PE (n=438)
Using <2,2-6 and >6 to classify the PE PTP score
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Other investigations performed
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Investigations performed and diagnosis
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Chest x-ray
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
The Royal Perth Hospital algorithm
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Treatment of patients with PE – location of treatment
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Suitability of PE patients for home treatment1 (n=457)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Doses of LMWH
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Average number of doses of LMWH for non-PE and PE patients; bars denote standard error
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Prediction of the risk of adverse events in PE patients
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Thromboprophylaxis
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Source of referral for medical inpatients with VTE
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Source of referral for surgical inpatients with VTE
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Source of referral for patients with a history of surgical inpatient stay and VTE (n=685)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Final diagnosis and inpatient history - Overview
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Final diagnosis and inpatient history
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Focus on medical inpatient history
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Medical inpatient history for each final diagnosis (n=21,080)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Focus on surgical inpatient history
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Surgical inpatient history for each final diagnosis (n=20,996)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Speciality for VTE patients who have recently had surgery (n=685)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Thromboprophylaxis provision for VTE patients (n=3,189)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Source of referral and the use of thromboptophylaxis for VTE patients (n=3,580)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Trends in the use of LMWH as thromboprophylasis for VTE patients (n=730)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Thromboprophylaxis and surgical speciality for VTE patients
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Thromboprophylaxis provision and surgical speciality for VTE patients (n=603)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Thromboprophylaxis and inpatient stay
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Type of thromboprophylaxis, final diagnosis and inpatient history
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Thromboprophylaxis and risk factors in medical inpatients with VTE
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Final diagnosis and new risk score
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Final diagnosis of VTE and weighted risk score (n=5,692)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Thromboprophylaxis and the weighted score
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Thromboprophylaxis and weighted risk score (n=4,794)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Kaplan-Meier survival curves for patients with confirmed diagnoses of DVT according to recent medical inpatient history (n=242 and n=1,883 respectively)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Kaplan-Meier survival curves for patients with confirmed diagnoses of DVT according to recent surgical inpatient history (n=266 and n=1,839 respectively)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Number of referrals over time according to patients’ history and Percentage of patients with confirmed VTE over time according to patients’ history
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Number of referrals over time according to patients’ history and Percentage of patients with confirmed VTE over time according to patients’ history
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
VTE and Cancer
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Cancer rates amongst VTE patients at each hospital
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Final diagnosis and cancer
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Presence of a final diagnosis of VTE in cancer and non-cancer patients
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Cancer, age and gender in patients with VTE
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Cancer rates broken down by age and gender for patients with VTE (n=5,655)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Specific type of cancer and age for patients with VTE
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Specific type of cancer and age for patients with VTE
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Cancer rates broken down by age for the most frequently occuring cancers in VERITY amongst patients with VTE (n=5,582)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Specific type of cancer and final diagnosis
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Type of cancer and final diagnosis (n=1,205)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
D-dimer and cancer
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
D-dimer results in the context of cancer (n=15,240)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Location of treatment
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Location of treatment and cancer for VTE patients (n=5,480)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Doses of LMWH
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Duration of LMWH therapy and time to therapeutic INR in patients with DVT in the context of cancer; patients receiving both therapies only (n=3,444)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Duration of LMWH therapy in patients with VTE in the context of cancer (n=4,138)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Kaplan-Meier survival curves for patients with confirmed diagnoses of VTE according to the presence of absence of cancer (n=2,224)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Walsgrave hospital: Cancer and medium-term mortality in VTE patients
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
VTE and Pregnancy
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Final diagnosis and pregnancy
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Final diagnosis and pregnancy (n=12,336)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Risk factors and pregnancy
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Final diagnosis and pregnancy (n=3,389)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Final diagnosis and selected risk factors amongst pregnant patients
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Investigations and pregnancy
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Investigations in pregnant patients
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Treatment and pregnancy – use of LMWH
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
LMWH use and final diagnosis for pregnant patients (n=378)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Doses of LMWH
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
LMWH doses and final diagnosis for pregnant patients;bars denote standard errors (n=89 and 50 respectively)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Warfarin therapy and post partum
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Warfarin use and final diagnosis for post partum patients (n=425)
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Summary of protocol for thromboprophylaxis in women with previous VTE and / or thrombophiliai
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
A clinical model for predicting pre-test probability for deep vein thrombosisi
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
Variables used to determine a pre-test probability score in patients with suspected pulmonary embolismii
VERITY (Venous Thromboembolism Registry) Third Annual Report 2005
A new weighted score to determine the risk of VTEiii
top related